Navigating Mental Health Care: When to Consider Neurotherapy
Navigating Mental Health Care: When to Consider Neurotherapy By Charles Miller, CRNA, CMO, Founder/Owner of Scenic City Neurotherapy You don’t need another reminder to
Your comfort and health care needs are our utmost priority. We exclusively employ Certified Registered Nurse Anesthesiologists (CRNAs) to administer ketamine treatments to patients. We promise to put our patient’s safety needs first, providing and delivering exceptional individualized care from assessment, through, and beyond stabilization therapy.
According to a study published in the National Library of Medicine in regards to Ketamine Infusion Therapy, the primary outcome of a randomized controlled trial of a single infusion of ketamine compared to an active placebo was a change in depression severity 24 hours after drug administration, as assessed by the Montgomery-Åsberg Depression Rating Scale (MADRS). The ketamine group had greater improvement in the MADRS score than the midazolam group 24 hours after treatment. After adjustment for baseline scores and site, the MADRS score was lower in the ketamine group than in the midazolam group by 7.95 points (95% confidence interval [CI], 3.20 to 12.71).
See more research and articles on ketamine infusion treatment here.
Navigating Mental Health Care: When to Consider Neurotherapy By Charles Miller, CRNA, CMO, Founder/Owner of Scenic City Neurotherapy You don’t need another reminder to
The Science Behind Transcranial Magnetic Stimulation (TMS) Therapy: Life After Treatment What Happens After TMS? Understanding the Long-Term Impact By Charles Miller, CRNA, CMO, Founder
How to Prepare for Your First TMS Session Understanding Transcranial Magnetic Stimulation (TMS) Therapy By Charles Miller, CRNA, CMO, Founder of Scenic City Neurotherapy
Monday: 9 A.M. – 7 P.M.
Tuesday: 9 A.M. – 7 P.M.
Wednesday: 9 A.M. – 7 P.M.
Thursday: 9 A.M. – 7 P.M.
Friday: 9 A.M. – 7 P.M.
Saturday: We’re Closed
Sunday: 9 A.M. – 7 P.M.
